{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/73441-062#drug","name":"APHEXDA","alternateName":"MOTIXAFORTIDE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"73441-062"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA217159"},{"@type":"PropertyValue","propertyID":"UNII","value":"3ZPX60DV8A"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"e704b2db-f119-40ba-9346-9229e3281c9e"}],"activeIngredient":"MOTIXAFORTIDE ACETATE","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Gamida Cell Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA217159","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e704b2db-f119-40ba-9346-9229e3281c9e","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73441-062"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-10-31T05:45:43.072Z"}}